Published in J Nanobiotechnology on June 23, 2016
Modeling tissue morphogenesis and cancer in 3D. Cell (2007) 7.49
Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer (2007) 6.58
Endocytosis of nanomedicines. J Control Release (2010) 3.23
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells. Biomaterials (2008) 1.91
Nanoparticles and the immune system. Endocrinology (2009) 1.79
Three-dimensional cell culture: the missing link in drug discovery. Drug Discov Today (2012) 1.63
Liposomes to target the lymphatics by subcutaneous administration. Adv Drug Deliv Rev (2001) 1.62
3D tumour models: novel in vitro approaches to cancer studies. J Cell Commun Signal (2011) 1.47
Fluid flow regulates stromal cell organization and CCL21 expression in a tissue-engineered lymph node microenvironment. J Immunol (2009) 1.30
Generation of a synthetic lymphoid tissue-like organoid in mice. Nat Biotechnol (2004) 1.23
3-D tissue culture systems for the evaluation and optimization of nanoparticle-based drug carriers. Bioconjug Chem (2008) 1.18
From seeing to believing: labelling strategies for in vivo cell-tracking experiments. Interface Focus (2013) 1.17
In vitro toxicity testing of nanoparticles in 3D cell culture. Small (2009) 1.17
Modelling tissues in 3D: the next future of pharmaco-toxicology and food research? Genes Nutr (2008) 1.16
Preclinical evaluation of docetaxel (Taxotere). Semin Oncol (1995) 1.11
Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting. Cancer Chemother Pharmacol (2006) 1.04
A human lymph node in vitro--challenges and progress. Artif Organs (2006) 0.99
Artificial lymph nodes induce potent secondary immune responses in naive and immunodeficient mice. J Clin Invest (2007) 0.96
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers. Biomacromolecules (2008) 0.93
A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics. Biomaterials (2014) 0.92
Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism. Cancer Res (2012) 0.90
Immunosuppression associated with novel chemotherapy agents and monoclonal antibodies. Clin Infect Dis (2014) 0.89
Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo. Mol Pharm (2013) 0.87
LyP-1-conjugated doxorubicin-loaded liposomes suppress lymphatic metastasis by inhibiting lymph node metastases and destroying tumor lymphatics. Nanotechnology (2011) 0.87
Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells. Int J Cancer (2012) 0.85
Recent advances in lymphatic targeted drug delivery system for tumor metastasis. Cancer Biol Med (2014) 0.84
Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate. Adv Cancer Res (2007) 0.84
An in vitro model of the tumor-lymphatic microenvironment with simultaneous transendothelial and luminal flows reveals mechanisms of flow enhanced invasion. Integr Biol (Camb) (2015) 0.84
Microenvironment of tumor-draining lymph nodes: opportunities for liposome-based targeted therapy. Int J Mol Sci (2014) 0.84
Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells. Cancer Chemother Pharmacol (2005) 0.83
Lymphatic biodistribution of polylactide nanoparticles. Mol Imaging (2010) 0.83
Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers. J Control Release (2014) 0.81
Analysis by high resolution ultrasound of superficial lymph nodes: anatomical, morphological and structural variations. Clin Imaging (2013) 0.79
Poly-L-asparagine nanocapsules as anticancer drug delivery vehicles. Eur J Pharm Biopharm (2013) 0.78
Polyaminoacid nanocapsules for drug delivery to the lymphatic system: Effect of the particle size. Int J Pharm (2016) 0.77
Intracellular delivery of docetaxel using freeze-dried polysaccharide nanocapsules. J Microencapsul (2012) 0.77
Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy. Curr Pharm Des (2016) 0.77
A new potential nano-oncological therapy based on polyamino acid nanocapsules. J Control Release (2013) 0.76